ArticleRSC advances2023

Isatin-based benzyloxybenzene derivatives as monoamine oxidase inhibitors with neuroprotective effect targeting neurogenerative disease treatment.

Feba Benny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.